莱美药业：全资子公司乳酸钠林格注射液获药品补充申请批准

Core Viewpoint - The announcement indicates that the wholly-owned subsidiary of the company, Hunan Kangyuan Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the sodium lactate Ringer's injection (specification: 500ml) [1] Group 1: Product Approval - The sodium lactate Ringer's injection has passed the consistency evaluation of quality and efficacy for generic drugs [1] - The approval allows for changes in the drug formulation, production process, quality standards, packaging materials, and containers, along with revisions to the drug instructions [1] - The validity period for the approval is set at 18 months [1]